5:35 PM
 | 
Feb 17, 2009
 |  BC Extra  |  Company News

Vion submits Onrigin NDA

Vion (OTCBB:VION) submitted an NDA to FDA for Onrigin laromustine injection to...

Read the full 47 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >